HR or Marketing? Claim Your Free Employer Account
Olivier Charmeil ā Executive Vice President of General Medicines & Emerging Markets at Sanofi
Executive Bio
Mr. Olivier Charmeil has been an Executive Vice President of General Medicines & Emerging Markets at Sanofi since July 6, 2017. Mr. Charmeil served as an Executive Vice President and General Manager of General Medicines & Emerging Markets at Sanofi since June 1, 2016 until July 6, 2017. Mr. Charmeil served as Chief Executive Officer and President at Sanofi Pasteur, SA. Mr. Charmeil served as an Executive Vice President of Vaccines at Sanofi since January 01, 2011 until June 1, 2016. He served as Executive Vice President of Pasteur Division at Sanofi. He served as Senior Vice President of Vaccines Division at Sanofi Pasteur since January 1, 2011. He served as the Senior Vice President of Pharmaceutical Operations, Asia Pacific and Japan at Sanofi-Aventis (now, Sanofi) since January 1, 2008. Mr. Charmeil served as a Senior Vice President of Pharmaceutical Operations of Asia Pacific of Sanofi-Aventis (now, Sanofi) from February 1, 2006 to January 1, 2008. From 1989 to 1994, he worked in the Mergers & Acquisitions department of Banque de l'Union Europ??enne. He joined Sanofi Pharma in 1994 as Head of Business Development. Subsequently, he held various posts within Sanofi Pharma, including Chief Financial Officer of Asia for Sanofi-Synth??labo (now, Sanofi) since 1999 and Attach?? to the Chairman, Jean-Fran??ois Dehecq since 2000. He served as Vice President of Development within Sanofi-Synth??labo International Operations Directorate, where he was responsible for China and support functions. Mr. Charmeil served as Vice President of Overseas Sales of Sanopi Synthelabo France Inc. since 2002 and President since 2003. He served as Vice President of Management and Medicine Sales Division of Sanopi-Aventis since 2004 and also served as its Senior Vice President of Business Management and Support within the Pharmaceutical Operations Directorate. Mr. Charmeil served as the Chairman and Chief Executive Officer of Sanofi-Synth??labo France since 2003. He serves as a Member of Supervisory Board at Hoechst GmbH. He serves as a Director of Shantha Biotechnics Limited. He has been a Member of Supervisory Board at Hoechst GmbH since June 2005. He served as a Director of at Sanofi India Limited (formerly Aventis Pharma Ltd.) from October 30, 2006 to August 23, 2011. He served as a Director of Handok Inc. (alternate name Handok Pharmaceuticals Co., Ltd). Since October 2014, he represents the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) at the Gavi Alliance Board for a three-year term. Mr. Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and the Institut d'Etudes Politiques in Paris.
Executive Team Culture Ratings from Sanofi Employees
TOP
20%
Sanofi's Executive Team scores in the Top 20%
of similar sized companies on Comparably
of similar sized companies on Comparably
Sanofi's Executive Team at a Glance
Based on 137 ratings, Sanofi's employees are satisfied with their Executive Team and give them a āB+ā or 74/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the Marketing department thinks more highly of the Executive Team relative to the Operations department.
Sanofi's Executive Team ranks in the Top 30% of other companies in New York and Top 20% of other companies on Comparably that also have 10,000+ Employees.
×